随机研究评估了风味对干燥和潮湿尼古丁袋的药理动力学和主观参数的影响
Mikael Staaf1, Anna E Masser1, Camilla Pramfalk1
1Regulatory & Scientific Affairs, Swedish Match North Europe AB, Box 17037, Stockholm SE-104 62, Sweden.
Drug and alcohol dependence
|January 24, 2026
概括
尼古丁袋 (NPs) 中的调味通常不会改变尼古丁的吸收,但湿薄荷品种显示出差异. 参与者的偏好有所不同,这表明需要多样化的NP选项.
科学领域:
- 药理学 药理学是指药理学的学科.
- 消费产品分析 消费产品分析
背景情况:
- 尼古丁袋 (NPs) 在各种配方和风味中可供选择.
- 香味对尼古丁药理学和用户体验的影响尚不清楚.
研究的目的:
- 研究尼古丁袋中的不同口味对尼古丁药理动力学和主观用户体验的影响.
- 为了比较干燥和潮湿的尼古丁袋配方.
主要方法:
- 来自两个随机,交叉的药理动力学和主观效应研究的数据分析.
- 评估干燥的 (6毫克) 和潮湿的 (9毫克) 尼古丁袋,包括无味和有味道的品种 (烟草,冷却,薄荷,水果,饮料).
- 参与者是每天使用鼻和/或尼古丁袋 (n=38-39) 的用户.
主要成果:
- 尼古丁吸收 (Cmax和AUCinf) 对于干燥和潮湿的尼古丁袋是相似的,除了两个潮湿的薄荷品种外,无味和风味类型之间的等价性.
- 味道对达到最大尼古丁度 (Tmax) 的时间没有显著影响.
- 与无调味版本相比,调味湿尼古丁袋在满意度,喜欢度和再次使用的意图方面被评为更高.
结论:
- 味道通常不会影响干燥尼古丁袋中的尼古丁药理动力学 (Cmax,AUCinf,Tmax).
- 两种湿薄荷尼古丁袋品种与无味湿袋相比,显示出药理学差异.
- 用户偏好的显著差异凸显了需要多样化的尼古丁袋产品和风味的需求.
相关概念视频
00:54Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
439
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
439
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
159
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
159
01:06Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
247
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
247
01:17Assessment of the Gastrointestinal System I: Subjective Data
637
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
637
01:23Assessment of the Cardiovascular System I: Subjective Data
785
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
785
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
243
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
243